Gastric Cancer
Why trials studying Gastric Cancer stopped, in this sample of ClinicalTrials.gov.
17 stopped trials with a clear reason; 94% ended for non-scientific reasons.
| Reason | Trials | Share |
|---|---|---|
| slow enrollment | 8 | 47% |
| funding or business | 7 | 41% |
| staffing, sites or logistics | 1 | 6% |
| other | 1 | 6% |
Trials
- Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
NCT06090318 · WITHDRAWN · funding or business
“Sponsor Decision” - Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.
NCT05687617 · TERMINATED · slow enrollment
“Recruitment lower than expected and negative results.” - A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors
NCT05572684 · TERMINATED · funding or business
“Following completion of Phase 1b, the Sponsor decided not to initiate Part 2 of the trial.” - Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC)
NCT05431244 · WITHDRAWN · slow enrollment
“Research withdrawal before patient registration due to difficulty in continuing research” - A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
NCT04260802 · TERMINATED · funding or business
“Business Decision” - Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer
NCT04294784 · TERMINATED · slow enrollment
“slow recruitment forcing early suspension of screening and enrollment” - Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
NCT04106167 · TERMINATED · funding or business
“This study was terminated by the Sponsor.” - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
NCT03745326 · TERMINATED · slow enrollment
“Study was closed due to lack of accrual and study outcomes overlapped with another protocol's eligibility.” - A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
NCT03829501 · TERMINATED · funding or business
“Early discontinuation based on strategic sponsor decision not driven by any safety concerns.” - Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples
NCT03721042 · TERMINATED · staffing, sites or logistics
“no PI to continue the study” - RCT of Mobile Apps & FitBit v. Usual Care
NCT03623464 · SUSPENDED · other
“Study is paused for interim analysis.” - Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer
NCT02867839 · TERMINATED · slow enrollment
“The number of patients enrolled was much less than expected” - Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
NCT02358863 · TERMINATED · slow enrollment
“Issues with recruitment.” - Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer
NCT01123473 · TERMINATED · funding or business
“company withdrew interest” - A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.
NCT01219543 · TERMINATED · funding or business
“Compound development discontinued” - The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding
NCT02150447 · TERMINATED · slow enrollment
“Low enroll rate” - A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression
NCT02005484 · TERMINATED · slow enrollment
“Study terminated due to slow patient recruitment.”
Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.